Chemotherapy for advanced colorectal cancer : It can improve quality of care and offer modest increases in survival

Por Michael, M, Zalcberg, J R
Publicado em 2000

Serum methotrexate in childhood ALL.

Por Cosolo, W., Siderov, J., Zalcberg, J.
Publicado em 1992

Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.

Por Zalcberg, J. R., Friedlander, M. L., Minden, M. D.
Publicado em 1986

Quality of pharmacokinetic research in oncology.

Por Siderov, J., Brien, J. E., Morgan, D. J., Zalcberg, J., Cosolo, W.
Publicado em 1995

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

Por Parisot, J P, Hu, X F, DeLuise, M, Zalcberg, J R
Publicado em 1999

Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients

Por Goldstein, D, Mitchell, P, Michael, M, Beale, P, Friedlander, M, Zalcberg, J, White, S, Clarke, S
Publicado em 2005

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line

Por Hu, X F, Slater, A, Rischin, D, Kantharidis, P, Parkin, J D, Zalcberg, J
Publicado em 1999

Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation

Por Leong, T, Michael, M, Foo, K, Thompson, A, Joon, D Lim, Weih, L, Ngan, S, Thomas, R, Zalcberg, J
Publicado em 2003

A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer

Por Ngan, S Y K, Michael, M, Mackay, J, McKendrick, J, Leong, T, Lim Joon, D, Zalcberg, J R
Publicado em 2004

Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

Por Hu, X. F., Slater, A., Wall, D. M., Kantharidis, P., Parkin, J. D., Cowman, A., Zalcberg, J. R.
Publicado em 1995

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

Por Tebbutt, N C, Cummins, M M, Sourjina, T, Strickland, A, Van Hazel, G, Ganju, V, Gibbs, D, Stockler, M, Gebski, V, Zalcberg, J
Publicado em 2010

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial

Por Loi, S, Ngan, S Y K, Hicks, R J, Mukesh, B, Mitchell, P, Michael, M, Zalcberg, J, Leong, T, Lim-Joon, D, Mackay, J, Rischin, D
Publicado em 2005

Rapid screening for depression – validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients

Por Jefford, M, Mileshkin, L, Richards, K, Thomson, J, Matthews, J P, Zalcberg, J, Jennens, R, McLachlan, S-A, Wein, S, Antill, Y, Clarke, D M
Publicado em 2004

Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.

Por de Silva, M., Kantharidis, P., Wall, D. M., Campbell, L., Vrazas, V., Nadalin, G., Kaczmarczyk, S. J., Hu, X. F., Parkin, J. D., Zalcberg, J. R.
Publicado em 1996

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.

Por Smith, I., Jones, A., Spielmann, M., Namer, M., Green, M. D., Bonneterre, J., Wander, H. E., Hatschek, T., Wilking, N., Zalcberg, J., Spiers, J., Seymour, L.
Publicado em 1996

A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer

Por Michael, M, Price, T, Ngan, S Y, Ganju, V, Strickland, A H, Muller, A, Khamly, K, Milner, A D, Dilulio, J, Matera, A, Zalcberg, J R, Leong, T
Publicado em 2009

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study

Por Millward, M J, House, C, Bowtell, D, Webster, L, Olver, I N, Gore, M, Copeman, M, Lynch, K, Yap, A, Wang, Y, Cohen, P S, Zalcberg, J
Publicado em 2006

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

Por Day, F L, Leong, T, Ngan, S, Thomas, R, Jefford, M, Zalcberg, J R, Rischin, D, McKendick, J, Milner, A D, Di Iulio, J, Matera, A, Michael, M
Publicado em 2011

Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer

Por Michael, M, Chander, S, McKendrick, J, MacKay, J R, Steel, M, Hicks, R, Heriot, A, Leong, T, Cooray, P, Jefford, M, Zalcberg, J, Bressel, M, McClure, B, Ngan, S Y
Publicado no Br J Cancer (2014)

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

Por Bleiberg, H., Decoster, G., de Gramont, A., Rougier, P., Sobrero, A., Benson, A., Chibaudel, B., Douillard, J. Y., Eng, C., Fuchs, C., Fujii, M., Labianca, R., Larsen, A. K., Mitchell, E., Schmoll, H. J., Sprumont, D., Zalcberg, J.
Publicado no Ann Oncol (2017)